| Completed | An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life i Early Breast Cancer, Skin Condition, Quality of Life | — | 2024-11-22 |
| Recruiting | FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations Solid Tumor, MET Alteration | Phase 1 / Phase 2 | 2024-10-22 |
| Recruiting | Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs Non-small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2024-09-17 |
| Recruiting | To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatmen Advanced Breast Cancer | — | 2024-09-10 |
| Terminated | The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-u Sore-throat, Cough | — | 2024-03-14 |
| Recruiting | First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lun Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation | Phase 1 / Phase 2 | 2023-09-26 |
| Active Not Recruiting | Characteristics and Impacts of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) in Boys: An Observational In X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) | — | 2023-07-19 |
| Completed | Study on Structum® in Adult Patients With Osteoarthritis (TRUST) Osteoarthritis, Knee | — | 2023-06-27 |
| Not Yet Recruiting | Treatment Patterns of Neratinib in HER2+ EBC in China Breast Cancer | — | 2022-09-30 |
| Withdrawn | Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema Chronic Hand Eczema | — | 2022-09-07 |
| Completed | Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations Melanoma, BRAF V600 Mutation, Unresectable Melanoma | Phase 1 | 2022-08-31 |
| Completed | A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Ner Breast Cancer, Adjuvant Therapy, HER2-positive Breast Cancer | — | 2022-07-05 |
| Completed | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) Metastatic Non-small Cell Lung Cancer, BRAF V600 Mutation | — | 2022-06-23 |
| Completed | A 6-months Observational Study to Evaluate the Quality of Life of Patients Treated With Phytotherapy or Alpha- Benign Prostatic Hyperplasia | — | 2022-06-22 |
| Active Not Recruiting | Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Pati Non-Small Cell Lung Cancer | Phase 2 | 2022-06-02 |
| Active Not Recruiting | Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation. Melanoma | Phase 3 | 2022-05-02 |
| Completed | Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumor BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma | Phase 1 | 2021-09-27 |
| Completed | A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fl BRAF V600E, Metastatic Colorectal Cancer | Phase 2 | 2021-09-14 |
| Unknown | Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations Melanoma, BRAF V600 Mutation, Unresectable Melanoma | Phase 1 | 2021-09-03 |
| Active Not Recruiting | A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma | Phase 1 | 2021-08-04 |
| Recruiting | A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD) | Phase 2 | 2021-07-14 |
| Completed | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emol Actinic Keratoses | Phase 4 | 2021-02-16 |
| Completed | A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Melanoma (Skin), Metastatic Melanoma, BRAF V600 Mutation | — | 2021-02-02 |
| Withdrawn | Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma BRAF V600 Mutation, Unresectable Melanoma, Metastatic Melanoma | Phase 1 | 2021-01-21 |
| Terminated | First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Local Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2020-09-08 |
| Completed | A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic BRAF V600E Mutation Positive, Metastatic Colorectal Cancer | — | 2020-04-12 |
| Completed | Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer BRAF V600E-mutant Metastatic Colorectal Cancer | Phase 2 | 2019-01-17 |
| Recruiting | A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphopro Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders | Phase 3 | 2017-12-29 |
| Terminated | A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors | Phase 1 / Phase 2 | 2017-11-24 |
| Withdrawn | EXPLORATORY ASSESSMENT OF THE EFFECTS OF CYCLO 3 ® FORT (Ruscus Extract, Hesperidin Methyl Chalcone, Ascorbic Venous Disease Classification (CEAP): C2 or C3 | Phase 2 | 2016-12-01 |
| Terminated | Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia Iron Deficiency Anemia | Phase 1 | 2015-08-01 |
| Completed | Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extra Alveolar Osteitis | Phase 4 | 2015-03-01 |
| Completed | Assessment of V0018 2.5 mg Effect on Craving Healthy Highly Dependant Smokers | Phase 2 | 2015-02-01 |
| Completed | Assessment of V0018 1.5 mg Effect on Craving Smoking | Phase 2 | 2015-02-01 |
| Completed | F17464 in Acute Schizophrenia Trial Schizophrenia | Phase 2 | 2014-06-01 |
| Completed | Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cance Recurrent or Metastatic Head and Neck Carcinoma | Phase 3 | 2014-04-25 |
| Completed | Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging Subject | Phase 1 | 2014-04-01 |
| Completed | PERmixon® in LUTS Evaluation Study (PERLES) Benign Prostatic Hyperplasia (BPH) | Phase 4 | 2014-04-01 |
| Completed | Nicotine Patch - Bioequivalence Study Healthy Smokers | Phase 1 | 2014-03-01 |
| Completed | Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy. Open Cracked Heel in Diabetic Patients With Polyneuropathy | N/A | 2014-02-01 |
| Completed | Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia Drug-induced Xerostomia | N/A | 2013-12-01 |
| Completed | Bronchodilator Properties and Safety in Asthma Asthma | Phase 2 | 2013-09-01 |
| Completed | CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study Recurrent Upper-Respiratory Tract Infections | Phase 3 | 2013-09-01 |
| Completed | Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Can Malignant Neoplasm of Breast | Phase 3 | 2013-09-01 |
| Completed | Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administration Healthy Volunteers | Phase 1 | 2013-05-01 |
| Completed | Efficacy and Safety Study of F373280 Atrial Fibrillation | Phase 2 | 2013-04-01 |
| Completed | Ibuprofen Lozenge in Acute Sore Throat Pain Acute Sore Throat Pain | Phase 3 | 2013-02-01 |
| Completed | Emollients in the Management of Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2013-02-01 |
| Completed | Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia Iron Deficiency Anemia | Phase 1 | 2013-01-01 |
| Completed | Brain Imaging Study of F17464 Healthy Volunteers | Phase 1 | 2012-11-01 |
| Completed | Nicotine Patch - Multidose Bioequivalence Study Healthy Smokers | Phase 1 | 2012-08-01 |
| Completed | Nicotine Patch Bioequivalence Study Healthy Smokers | Phase 1 | 2012-08-01 |
| Completed | Nicotine Patch Safety Study Smokers | Phase 2 | 2012-08-01 |
| Completed | Effect of F2695 on Functional Recovery After Ischemic Stroke Ischemic Stroke | Phase 3 | 2012-07-01 |
| Completed | Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Vers Benign Prostatic Hyperplasia (BPH) | Phase 4 | 2012-06-01 |
| Completed | Effect of V0251 in Acute Vertigo Acute Vertigo | Phase 2 | 2012-04-01 |
| Completed | Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations Healthy Smokers | Phase 1 | 2012-03-01 |
| Completed | Acute Sore Throat Pain Study Acute Sore Throat Pain | Phase 2 | 2012-02-01 |
| Completed | Efficacy Emollient on Xerosis in Children With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2011-11-01 |
| Completed | Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162 Chronic Obstructive Pulmonary Disease | Phase 1 / Phase 2 | 2011-04-01 |
| Completed | JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Bladder Transitional Cell Carcinoma Stage IV | Phase 2 | 2011-02-01 |
| Completed | Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patien Chronic Venous Insufficiency (CVI) | Phase 3 | 2011-01-01 |
| Completed | Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer Breast Cancer, Metastases | Phase 3 | 2009-07-01 |
| Completed | Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer Breast Cancer | Phase 3 | 2009-05-01 |
| Completed | Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Breast Cancer | Phase 2 | 2007-03-27 |
| Completed | FMS European Long-Term Study Fibromyalgia Syndrome | Phase 3 | 2006-09-01 |
| Completed | Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran Fibromyalgia Syndrome | Phase 2 | 2006-09-01 |
| Terminated | A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Can Advanced Breast Cancer | Phase 3 | 2006-06-01 |
| Completed | A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndr Fibromyalgia Syndrome | Phase 3 | 2006-02-01 |
| Completed | Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Transitional Cell Carcinoma of the Urothelial Tract, Bladder Cancer, Bladder Neoplasms | Phase 3 | 2005-07-01 |
| Completed | Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy Lung Cancer | Phase 2 | 2005-05-01 |
| Completed | Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy I NSCLC | Phase 3 | 2005-04-01 |
| Withdrawn | Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis Knee Osteoarthritis | N/A | — |